In Silico Modeling Unveils a New Era in Rare Disease Drug Development
The Premier Consulting Blog
JUNE 18, 2023
Figure 1: Comparison of Clinical Trial Designs The Prelude to Applying In Silico Trials for Rare Diseases In silico clinical trials have been recognized by the FDA as useful tools in advancing personalized treatment and streamlining randomized controlled trials. BMC Bioinformatics 2020, 21(Suppl 17):527 [link]
52 
Let's personalize your content